-       Report 
- February 2025
-  182 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- February 2025
-  182 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
          -       Report 
- January 2025
-  182 Pages 
- Global 
   From       €4025EUR$4,500USD£3,541GBP 
            -       Report 
- October 2025
-  190 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
            -       Report 
- August 2025
-  183 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
             -       Report 
- August 2025
-  198 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  289 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  604 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  245 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- October 2025
-  179 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- April 2025
-  175 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- April 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
          -       Report 
- January 2025
-  175 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
            -       Report 
- September 2025
-  150 Pages 
- Global 
   From       €3980EUR$4,450USD£3,501GBP 
            -       Report 
- August 2025
-  150 Pages 
- Global 
   From       €3003EUR$3,358USD£2,642GBP 
      €3533EUR$3,950USD£3,108GBP 
          -       Report 
- July 2025
-  350 Pages 
- Global 
   From       €4427EUR$4,949USD£3,894GBP 
       
      Blood Plasma is a vital component of the pharmaceutical industry, used in the production of a variety of drugs and treatments. It is a component of the human body that is collected from healthy donors and used to create a range of products, including immunoglobulins, albumin, clotting factors, and other proteins. Plasma is also used to manufacture a variety of vaccines, including those for influenza, hepatitis, and rabies.
The demand for blood plasma has grown in recent years due to the increasing    prevalence of chronic diseases and the need for more effective treatments. As a result, the market for blood plasma has become increasingly competitive, with a number of companies vying for a share of the market.
Some of the major players in the blood plasma market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. These companies are involved in the collection, processing, and distribution of blood plasma products, as well as the development of new treatments and therapies. Show Less   Read more